ABHD14A-ACY1

Aminoacylase-1 UniProt accession Q03154

Aminoacylase involved in the hydrolysis of N-acetylated and N-formylated amino acids. May act sequentially with APEH in the degradation of N-acylated peptides: APEH first cleaves N-acylaminoacids from N-acylated peptides, then ACY1 further hydrolyzes the N-acylaminoacid into free aminoacid and a carboxylate

Source: UniProt

Homodimer. Interacts with SPHK1 (By similarity)

Source: UniProt
Cytoplasm
Source: UniProt

Expression is highest in kidney, strong in brain and weaker in placenta and spleen

Source: UniProt
  • Aminoacylase-1 deficiency (ACY1D)

    An enzymatic deficiency resulting in encephalopathy, unspecific psychomotor delay, psychomotor delay with atrophy of the vermis and syringomyelia, marked muscular hypotonia or normal clinical features. Epileptic seizures are a frequent feature. All affected individuals exhibit markedly increased urinary excretion of several N-acetylated amino acids.

Source: UniProt
  • Aflatoxin activation and detoxification
  • Defective ACY1 causes encephalopathy
  • Paracetamol ADME
Source: Reactome via UniProt

Mutations

No mutation information available.

Synthetic Lethal Network

Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to ABHD14A-ACY1, aggregated across our SSL data sources. Click any partner node to view that gene’s page.

Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.

BioGRID SLOrth SynLethDB MexDrugs Multi-source
Sources: BioGRID, SLOrth, SynLethDB, MexDrugs

Clinical Trials

No clinical trials information available.